Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Berrè, Patrizio
DOB: 21-FEB-1949 (Age: 77)
Gender: male
Address:
Via Bossi, 62
31040 Fanzolo (Italy)
ID: 3822-672758-4 (ECI)
Report
Date: 03-AUG-2024
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedale Vecchio di Montebelluna
Via Sant'Andrea nan
31044 Montebelluna (Italy)
Specimen
Collected: 03-AUG-2024

Hematology

Test 03-AUG-2024 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 7.6 4.5 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.6 4.3 - 5.7 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.2 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 42.8 39 - 50 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 79.1 L 80 - 100 fL
MCH [Entitic mass] by Automated count 31.4 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 33.6 32 - 36 g/dL
Erythrocyte [DistWidth] in Blood by Automated count 12.9 11.5 - 14.5 %
Platelets [#/volume] in Blood by Automated count 390.8 150 - 450 10*3/uL

Chemistry

Test 03-AUG-2024 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 98.1 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 18.5 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 2.7 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.0 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Serum or Plasma 136.8 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 3.8 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 108.6 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 22.5 22 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.4 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.0 3.5 - 5.5 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 13.4 H 0.1 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 58.7 30 - 120 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 4.2 L 10 - 40 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23.5 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 1.9 1.6 - 2.6 mg/dL
Phosphate [Mass/volume] in Serum or Plasma 4.3 2.5 - 4.5 mg/dL
pH of Arterial blood 7.1 L 7.35 - 7.45 [pH]
Carbon dioxide [Partial pressure] in Arterial blood 39.4 35 - 45 mm[Hg]
Oxygen [Partial pressure] in Arterial blood 95.9 80 - 100 mm[Hg]
Bicarbonate [Moles/volume] in Arterial blood 22.2 22 - 28 mmol/L
Oxygen saturation in Arterial blood 97.0 95 - 100 %
Cholesterol [Mass/volume] in Serum or Plasma 160.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 138.6 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 80.3 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 52.5 40 - 60 mg/dL

Coagulation

Test 03-AUG-2024 Reference Range Unit
Prothrombin time (PT) 10.6 L 11.0 - 13.5 s
INR in Platelet poor plasma by Coagulation assay 0.9 0.9 - 1.1 {INR}
aPTT in Blood by Coagulation assay 37.6 H 24 - 32 s

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, total bilirubin, chloride, and aPTT, with low MCV, ALT, PT, and arterial pH. These findings suggest impaired renal function, possible cholestasis or hemolysis, mild microcytosis, and metabolic acidosis. Liver synthetic function appears preserved. Coagulation abnormalities and acidosis require urgent clinical correlation and further evaluation. Other parameters are within normal limits.